GRHL2
protein-codinggrainyhead like transcription factor 2
Gene summary
The protein encoded by this gene is a transcription factor that can act as a homodimer or as a heterodimer with either GRHL1 or GRHL3. Defects in this gene are a cause of non-syndromic sensorineural deafness autosomal dominant type 28 (DFNA28).[provided by RefSeq, Mar 2009]
- DFNA28
- TFCP2L3
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~177.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014460
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0012083
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0054832
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0012083
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0020364
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014460
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0019497
Submitter: ClinGen
GRHL2 was first associated with autosomal dominant non-syndromic hearing loss as early as 2002 (Peters et al., PMID: 12393799). At least 7 unique variants (frameshift, splice site, exon deletion) have been reported in humans. This association was made using case-level data, animal models, expression studies, and protein interaction studies. Association is seen in at least 8 probands in 5 publications and 2 ClinVar SCVs (PMIDs: 12393799, 23813623, 25342930, 27911912, 32048449, SCV000575569.4, SCV000344371.3). Variants in this gene segregated with disease in 16 additional family members (PMIDs: 12393799, 23813623, 32048449). The mechanism for disease is haploinsufficiency (PMID: 12393799, 23813623, 25342930). This gene-disease association is supported by a zebrafish transposon-mediated gene trap model and mRNA rescue, expression studies in the inner ear of mice, and protein interaction studies showing GRHL2's interaction with claudins. In summary, GRHL2 is definitively associated with autosomal dominant non-syndromic hearing loss.
Inheritance Pattern: AR
Disease ID:MONDO:0014460
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0019587
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0020364
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014460
Submitter: Orphanet
Inheritance Pattern: Unknown
Disease ID:MONDO:0007614
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0012083
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014460
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Dental; Dermatologic; Musculoskeletal; Ophthalmologic
Intervention: Audiologic/Otolaryngologic; Ophthalmologic
Rationale: For Corneal dystrophy, posterior polymorphous, 4, individuals may have secondary glaucoma, and awareness may allow surveillance, prompt diagnosis, and management to prevent visual loss; For Ectodermal dysplasia/short stature syndrome, early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GRHL2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_024915.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 45 | 2 | 51 | ||
| missense | 1 | 1 | 145 | 6 | 1 | 154 |
| nonsense | 4 | 5 | 1 | 10 | ||
| start loss | 0 | |||||
| frameshift | 5 | 1 | 1 | 7 | ||
| splice donor/acceptor (+/-2bp) | 2 | 7 | 4 | 13 | ||
| Total | 12 | 14 | 155 | 51 | 3 | 235 |
Highest pathogenic variant AF is 0.00001187513
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_079191.2 | 16 | MANE Select | |
| Ensembl | ENSP00000495564.1 | 16 | MANE Select | |
| RefSeq | NP_001317522.1 | 15 | Standard | |
| RefSeq | NP_001427376.1 | 16 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| grhl2b | Danio rerio | Structure: otic epithelium Quality: decreased thickness abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Mesodermal Commitment Pathway
Biological Process
- neural tube closure
- cardiac ventricle morphogenesis
- epithelial cell morphogenesis
- regulation of transcription by RNA polymerase II
- cell adhesion
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- intronic transcription regulatory region sequence-specific DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- protein binding
Cellular Component
- nucleus
- nucleoplasm
- cell-cell junction
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000251808
- Coding exons
- 16
- Length
- 177295
- Individuals with no LoFs
- 125740
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 8
- Defined
- 125748
- p
- 0.0000318
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.93 | 246 | 347 | 0.709 | 0.0000205 | 4174 |
| Missense (PolyPhen) | 67 | 140.57 | 0.47664 | 1771 | ||
| Synonymous | -1.27 | 150 | 131 | 1.14 | 0.00000840 | 1106 |
| Loss of Function | 5.04 | 5 | 39.0 | 0.128 | 0.00000242 | 435 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000053 | 0.000053 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcription factor playing an important role in primary neurulation and in epithelial development (PubMed:29309642, PubMed:25152456). Binds directly to the consensus DNA sequence 5'-AACCGGTT-3' acting as an activator and repressor on distinct target genes (By similarity). During embryogenesis, plays unique and cooperative roles with GRHL3 in establishing distinct zones of primary neurulation. Essential for closure 3 (rostral end of the forebrain), functions cooperatively with GRHL3 in closure 2 (forebrain/midbrain boundary) and posterior neuropore closure (By similarity). Regulates epithelial morphogenesis acting as a target gene-associated transcriptional activator of apical junctional complex components. Up-regulates of CLDN3 and CLDN4, as well as of RAB25, which increases the CLDN4 protein and its localization at tight junctions (By similarity). Comprises an essential component of the transcriptional machinery that establishes appropriate expression levels of CLDN4 and CDH1 in different types of epithelia. Exhibits functional redundancy with GRHL3 in epidermal morphogenetic events and epidermal wound repair (By similarity). In lung, forms a regulatory loop with NKX2-1 that coordinates lung epithelial cell morphogenesis and differentiation (By similarity). In keratinocytes, plays a role in telomerase activation during cellular proliferation, regulates TERT expression by binding to TERT promoter region and inhibiting DNA methylation at the 5'-CpG island, possibly by interfering with DNMT1 enzyme activity (PubMed:19015635, PubMed:20938050). In addition, impairs keratinocyte differentiation and epidermal function by inhibiting the expression of genes clustered at the epidermal differentiation complex (EDC) as well as GRHL1 and GRHL3 through epigenetic mechanisms (PubMed:23254293). {ECO:0000250|UniProtKB:Q8K5C0, ECO:0000269|PubMed:19015635, ECO:0000269|PubMed:20938050, ECO:0000269|PubMed:20978075, ECO:0000269|PubMed:23254293, ECO:0000269|PubMed:25152456, ECO:0000269|PubMed:29309642, ECO:0000305|PubMed:12175488}.;
- Disease
- DISEASE: Deafness, autosomal dominant, 28 (DFNA28) [MIM:608641]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA28 is characterized by mild to moderate hearing loss across most frequencies that progresses to severe loss in the higher frequencies by the fifth decade. {ECO:0000269|PubMed:12393799}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ectodermal dysplasia/short stature syndrome (ECTDS) [MIM:616029]: An autosomal recessive ectodermal dysplasia syndrome characterized by nail dystrophy and/or loss, oral mucosa and/or tongue pigmentation, abnormal dentition, keratoderma affecting the margins of the palms and soles, focal hyperkeratosis of the dorsal aspects of the hands and feet, and short stature. {ECO:0000269|PubMed:25152456}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Corneal dystrophy, posterior polymorphous, 4 (PPCD4) [MIM:618031]: A subtype of posterior corneal dystrophy, a disease characterized by alterations of Descemet membrane presenting as vesicles, opacities or band-like lesions on slit-lamp examination and specular microscopy. In severe cases, corneal endothelial failure may occur and corneal transplantation is required to restore vision. Secondary complications are common and include corneal edema, glaucoma, iris adherence to the cornea, and corectopia. PPCD4 transmission pattern is consistent with autosomal dominant inheritance. {ECO:0000269|PubMed:29499165}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.152
Intolerance Scores
- LoFtool
- 0.241
- RVIS EVS
- -0.4
- RVIS percentile EVS
- 26.73
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.460
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |